CEO Jean Jacques Bienaime sold $3.9M of BioMarin Pharmaceutical Inc.

Sold$3,906,200

$97.66Price

40,000Shares

−7%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Mon, Apr 27. Filed Wed, Apr 29, 7:40 PM ET, after the close. Not investment advice.